Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis

Fig. 3

Detailed associations between serum IFN activity and EULAR/ACR-2019 criteria items of 10 domains in treatment-naive SLE patients. Associations between serum IFN activity and individual items that consist of EULAR/ACR-2019 criteria domains were assessed by the Mann-Whitney U test. p values < 0.05 were considered significant. C3/4, complement component 3/4; CL, cardiolipin; dsDNA, double-stranded DNA; EULAR/ACR-2019 criteria, 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for SLE; IFN, type I interferon; LN, lupus nephritis; Sm, Smith; U-pro, urine protein

Back to article page